Eight officer departures reported; small-cap delisting activity persists

Eight officer departures reported; small-cap delisting activity persists

A wave of officer departures across blue-chip and mid-cap names dominated red-flag filings in the past 72 hours, with no stated cause disclosed in initial 8-K filings. Edwards Lifesciences (EW), FedEx (FDX), Baxter International (BAX), ADT (ADT), Pool Corporation (POOL), Nu Skin Enterprises (NUS), Crescent Capital BDC (CCAP), and an unnamed officer at each entity filed Item 5.02 disclosures on May 8. In parallel, small-cap delisting activity continued: CRYO Cell International (CCME) reported a Nasdaq halt, while acquisition-stage SPACs Quetta (QETA) and La Rosa Holdings (LRHC) accumulated multiple delisting flags this week. Enhanced Group (ENHA) and Arrive AI (ARAI) also posted delisting notices alongside officer turnover. Fermi Inc. (FRMI) recorded five officer departures alone, raising governance questions in that micro-cap space. Broader pattern suggests seasonal executive transitions offset by technical small-cap equity pressures. Watch for any cause-of-departure amendments or proxy filings from blue-chip names in coming days.